The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors
BRAF 抑制剂 PLX4720 抑制 BRAFV600E 突变和正常甲状腺细胞中的 CXCL8 分泌：BRAF 抑制剂的进一步抗癌作用
期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-019-40818-w
Francesca Coperchini, Laura Croce, Marco Denegri, Oriana Awwad, Samuel Tata Ngnitejeu, Marina Muzza, Valentina Capelli, Francesco Latrofa, Luca Persani, Luca Chiovato, Mario Rotondi
